Antiemetic Prophylaxis for Chemotherapy-Induced Nausea and Vomiting.

@article{Navari2016AntiemeticPF,
  title={Antiemetic Prophylaxis for Chemotherapy-Induced Nausea and Vomiting.},
  author={Rudolph M. Navari and Matti Aapro},
  journal={The New England journal of medicine},
  year={2016},
  volume={374 14},
  pages={1356-67}
}
Chemotherapy-induced nausea and vomiting (chemotherapyinduced emesis) is a common treatment-related side effect that has a detrimental effect on the quality of life of patients with cancer and may lead to dose reductions in or discontinuation of chemotherapy. The development of new antiemetic agents has dramatically changed the landscape of chemotherapy-induced emesis. In the 1970s, prolonged hospital stays for nausea after chemotherapy were common practice.1 In 1979, a randomized trial… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 45 extracted citations

CINV: still troubling patients after all these years

Supportive Care in Cancer • 2018
View 3 Excerpts
Highly Influenced

References

Publications referenced by this paper.
Showing 1-10 of 71 references

Single-dose fosaprepitant for the prevenThe New England Journal of Medicine Downloaded from nejm.org at SAN DIEGO (UCSD) on April 6, 2016

S Grunberg, D Chua, A Maru
For personal use only. No other uses without permission. Copyright © 2016 Massachusetts Medical Society. All rights reserved. n engl j med 374;14 nejm.org April • 2016

Guidelines in Oncology

NCCN Clinical Practic
Antiemesis, version 2. Fort Washington, PA: Harborside Press, • 2015

Similar Papers

Loading similar papers…